NovoCure (NVCR) Tax Rate Growth (3y) (2017 - 2026)
NovoCure (NVCR) Tax Rate Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | NovoCure | 2.02 Bn | 1.58 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,923.00 |
| Mar 31, 2026 | 116.00 |
| Dec 31, 2025 | 5,475.00 |
| Sep 30, 2025 | -1,065.00 |
| Jun 30, 2025 | -1,196.00 |
| Mar 31, 2025 | 7,149.00 |
| Dec 31, 2024 | -1,595.00 |
| Sep 30, 2024 | -1,703.00 |
| Jun 30, 2024 | -3,622.00 |
| Mar 31, 2024 | 2,849.00 |
| Dec 31, 2023 | -6,646.00 |
| Sep 30, 2023 | -1,852.00 |
| Jun 30, 2023 | -6,566.00 |
| Mar 31, 2023 | -17,186.00 |
| Dec 31, 2022 | -38,216.00 |
| Sep 30, 2022 | 3,497.00 |
| Jun 30, 2022 | 285,070.00 |
| Mar 31, 2022 | -4,164.00 |
| Dec 31, 2021 | 4,095.00 |
| Sep 30, 2021 | 2,840.00 |